VP Planning

VP Planning 1.0.21

Publication date: February 4, 2026
Unique identifier (UDI): (01)03770029173050(8012)1021(21)01
Regulatory information
Please note that the selected software is considered as a prototype in your country and its use is strictly reserved for demonstration, research or educational purposes. Any other use is strictly forbidden, especially in humans for clinical purposes.

Intended use

Visible Patient Suite is medical imaging software that is intended to provide trained medical professionals with tools to aid them in reading, interpreting, reporting, and treatment planning for both pediatric and adult patients. Visible Patient Suite accepts DICOM compliant medical images acquired from a variety of imaging devices, including CT, MR.

This product is not intended for use with or for the primary diagnostic interpretation of Mammography images.

The software provides several categories of tools. It includes basic imaging tools for general images, including 2D viewing, volume rendering and 3D volume viewing, orthogonal Multi-Planar Reconstructions (MPR), image fusion, surface rendering, measurements, reporting, storing, general image management and administration tools, etc.

It includes a basic image processing workflow and a custom UI to segment anatomical structures, which are visible in the image data (bones, organs, vascular/airway structures, etc.), including interactive segmentation tools, basic image filters, etc. It also includes detection and labeling tools of organ segments (liver, lungs and kidneys), including path definition through vascular/airway, approximation of vascular/airway territories from tubular structures and interactive labeling.

The software is designed to be used by trained professionals (including physicians, surgeons and technicians) and is intended to assist the clinician who is solely responsible for making all final patient management decisions.

VP Planning is CE0459 marked and FDA cleared. It is strictly limited to healthcare professionals and can be used in clinical routine and/or for patient care in some specific countries. In other countries, the software is considered as a prototype and its use is strictly limited to demonstration, research or educational purposes. Any other use is strictly prohibited, in particular in humans for clinical purposes. It is authorized in the following countries:
  • Austria
  • Belgium
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Iceland
  • Ireland
  • Italy
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Portugal
  • Qatar
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • United States

System configuration

macOS

  • macOS 11
  • All Apple© computers sold since 2013
  • Graphic card: dedicated graphic card

Checksum:

sha256: 7845c2b8b7f92b82d6d629c2793fbd93d7611931b6919d9041369c35df208468

Windows

  • Windows 11 or later (64 bits)
  • Processor: Intel Core i3
  • Graphic card: dedicated graphic card (since 2020)
  • RAM: 4 Gb
  • Disk space: at least 100 Gb available
  • Broadband Internet connection
  • Media player: not required
  • Screen resolution: at least 1024×768

Checksum:

sha256: e269922c67bbd510496c850fa5e65ec40e1723511f58852c494a4aa8ab8a6ee0
Error when downloading file